Anlon Healthcare Ltd (AHCL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039733, "name": "Anlon Healthcare", "stock_name": "Anlon Healthcare", "full_name": "Anlon Healthcare Ltd", "name_url": "stocks-analysis/anlon-healthcare", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "16.30", "chg": 0.55, "chgp": "3.49%", "dir": 1, "prev_price": "15.75", "mcapval": "836.00 Cr", "mcap": "Micro Cap", "scripcode": 544497, "symbol": "AHCL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE0Y8W01025", "curr_date": "Jun 19, 03:30 PM", "curr_time": "10:07 AM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "78.59 lacs", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anlon-healthcare-10039733-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Anlon Healthcare Gains 0.07%: Key Growth and Quality Signals This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/anlon-healthcare-gains-007-key-growth-and-quality-signals-this-week-4051729", "imagepath": "", "date": "2026-06-13 15:03:47", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Q4 FY26 results reveal strong profit rebound amid margin pressure</p>\n <p><strong>2 June:</strong> Quality grade upgraded to average with a Hold rating and Mojo Score of 57.0</p>\n <p><strong>4 June:</strong> Stock surges 3.20% on heavy volume, reflecting investor interest</p>\n <p><strong>5 June:</strong> Week closes at Rs.13.99, marginally up by 0.07%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13.98</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\"..." }, { "title": "Anlon Healthcare Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/anlon-healthcare-ltd-is-rated-hold-by-marketsmojo-4050850", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnlonHealthcare_mojoScore_4050850.png", "date": "2026-06-13 10:10:51", "description": "Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 June 2026, providing investors with the most up-to-date view of its fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Anlon Healthcare Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/anlon-healthcare-ltd-is-rated-hold-by-marketsmojo-4030462", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnlonHealthcare_mojoScore_4030462.png", "date": "2026-06-02 10:10:51", "description": "Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Anlon Healthcare Ltd Quality Grade Upgraded to Average: A Detailed Fundamental Analysis", "link": "https://www.marketsmojo.com/news/stocks-in-action/anlon-healthcare-ltd-quality-grade-upgraded-to-average-a-detailed-fundamental-analysis-4029125", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnlonHealthcare_qualitydot_4029125.png", "date": "2026-06-02 08:01:16", "description": "Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade upgraded from 'Does Not Qualify' to 'Average' as of 1 June 2026. This shift reflects notable changes in the company’s business fundamentals, including profitability metrics, debt levels, and operational consistency. This article delves into the specifics of these improvements and areas where challenges remain, providing investors with a comprehensive view of Anlon Healthcare’s evolving financial health." }, { "title": "Anlon Healthcare Q4 FY26: Strong Profit Rebound Masks Margin Pressure and Valuation Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/anlon-healthcare-q4-fy26-strong-profit-rebound-masks-margin-pressure-and-valuation-concerns-4028877", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AnlonHealthcare_quaterlyResult_4028877.png", "date": "2026-05-30 16:58:31", "description": "Anlon Healthcare Ltd. delivered a robust profit recovery in Q4 FY26, posting consolidated net profit of ₹10.50 crores, marking a dramatic 103.88% sequential surge from the preceding quarter's ₹5.15 crores. The micro-cap pharmaceutical company, with a market capitalisation of ₹731.00 crores, demonstrated strong topline momentum as net sales climbed 43.03% quarter-on-quarter to ₹50.89 crores, though operating margins contracted to 30.05% from 34.49% in Q3 FY26. The stock closed at ₹13.59 on June 1, 2026, down 2.79% from the previous session, reflecting cautious investor sentiment despite the headline profit growth." } ], "total": 6, "sid": "10039733", "stock_news_url": "https://www.marketsmojo.com/news/anlon-healthcare-10039733" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Anlon Healthcare Ltd has announced <strong>2:10</strong> stock split, ex-date: 24 Apr 26", "dt": "2026-04-24", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Anlon Healthcare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Apr 26", "dt": "2026-04-24", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Q4 FY26 results reveal strong profit rebound amid margin pressure

2 June: Quality grade upgraded to average with a Hold rating and Mojo Score of 57.0

4 June: Stock surges 3.20% on heavy volume, reflecting investor interest

5 June: Week closes at Rs.13.99, marginally up by 0.07%

Week Open

Rs.13.98

Read full news article

Anlon Healthcare Ltd is Rated Hold by MarketsMOJO

2026-06-13 10:10:51

Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 June 2026, providing investors with the most up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anlon Healthcare Ltd is Rated Hold by MarketsMOJO

2026-06-02 10:10:51

Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Anlon Healthcare Ltd Quality Grade Upgraded to Average: A Detailed Fundamental Analysis

2026-06-02 08:01:16

Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade upgraded from 'Does Not Qualify' to 'Average' as of 1 June 2026. This shift reflects notable changes in the company’s business fundamentals, including profitability metrics, debt levels, and operational consistency. This article delves into the specifics of these improvements and areas where challenges remain, providing investors with a comprehensive view of Anlon Healthcare’s evolving financial health.

Read full news article

Anlon Healthcare Q4 FY26: Strong Profit Rebound Masks Margin Pressure and Valuation Concerns

2026-05-30 16:58:31

Anlon Healthcare Ltd. delivered a robust profit recovery in Q4 FY26, posting consolidated net profit of ₹10.50 crores, marking a dramatic 103.88% sequential surge from the preceding quarter's ₹5.15 crores. The micro-cap pharmaceutical company, with a market capitalisation of ₹731.00 crores, demonstrated strong topline momentum as net sales climbed 43.03% quarter-on-quarter to ₹50.89 crores, though operating margins contracted to 30.05% from 34.49% in Q3 FY26. The stock closed at ₹13.59 on June 1, 2026, down 2.79% from the previous session, reflecting cautious investor sentiment despite the headline profit growth.

Read full news article